Nolte Alexander
SEC CIK 1891979 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | CAO | 0 | — | $16.1K | 2 | 2022-01-31 | 2022-02-01 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Nolte Alexander made no open-market trades at SNDX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-01-31 | SNDX | Syndax Pharmaceuticals Inc | Nolte Alexander | CAO | J - Other | $12.39 | +968 | 968 | New | +$12.0K |
| D | 2022-02-03 | 2022-02-01 | SNDX | Syndax Pharmaceuticals Inc | Nolte Alexander | CAO | S - Sale | $16.65 | -968 | 0 | -100% | -$16.1K |
Purchase Sale Sale after option exercise All abbreviations